Search Results 161-170 of 17564 for mumps

  1. Publications - Matthew J. Binnicker, Ph.D. - Mayo Clinic

    Detection of IgG-class antibodies to measles, mumps, rubella, and varicella-zoster virus using a multiplex bead immunoassay. Diagn Microbiol Infect Dis. 2010 ...

  2. Health care maintenance in patients with IBD - Mayo Clinic

    Live vaccines, such as the varicella vaccine, the measles, mumps and rubella (MMR) vaccine, and the live influenza vaccine, are typically contraindicated in ...

  3. History of SARS/MERS: Outbreaks and vaccine timeline

    Trivalent combined measles-mumps-rubella vaccine. JAMA. 1971;218:57. Klein NP. Licensed pertussis vaccine in the United States: History and current state ...

  4. Infectious Diseases - Page 112 of 134 - Mayo Clinic News Network

    Infectious Diseases A-Z: Mumps outbreaks in the U.S.. Deb Balzer. April 3, 2017. Infectious Diseases A-Z: Rise in multidrug ...

  5. Transverse myelitis: Know the signs and symptoms

    Mumps, measles and rubella. Other viruses may trigger an autoimmune reaction without directly infecting the spinal cord. Bacterial infections that are ...

  6. Hydrocephalus - Symptoms and causes - Mayo Clinic

    Infections in the brain or spinal cord, such as meningitis or mumps. Bleeding in the brain caused by a stroke or head injury. Other types of brain injury ...

  7. Herd immunity and COVID-19: What you need to know - Mayo Clinic

    So keeping at least 95% of people vaccinated against the measles virus is a public health goal. At that level, people who can't get the vaccine, such as ...

  8. Melphalan (intra-arterial route, intravenous route) - Side effects & uses - Mayo Clinic

    Mumps Virus Vaccine, Live; Rubella Virus Vaccine, Live; Smallpox Monkeypox Vaccine; Typhoid Vaccine; Varicella Virus Vaccine, Live; Yellow Fever Vaccine. Using ...

  9. History of rabies: Outbreaks and vaccine timeline

    Trivalent combined measles-mumps-rubella vaccine. JAMA. 1971;218:57. Klein NP. Licensed pertussis vaccine in the United States: History and current state ...

  10. A Study to Assess the Effectiveness and Safety of Golimumab in Pediatric Participants With Moderately-to-Severely Active Ulcerative Colitis - Mayo Clinic

    Acceptable evidence of immunity to measles, mumps, rubella, and varicella. Exclusion Criteria: History of liver or renal insufficiency; significant cardiac ...